Radiotherapy for prostate cancer: best clinics abroad

Radiotherapy for prostate cancer can be a primary local treatment, part of care with hormone therapy, or treatment for suspected recurrence after prostate surgery. The target and purpose depend on the disease stage, risk group, prostate-specific antigen level, biopsy findings and previous treatment. Some lower-risk cancers are better managed initially with active surveillance, so an immediate radiation course is not necessary for every diagnosis.

Options include external beam radiation and brachytherapy in suitable patients. Radiopharmaceutical treatment for selected advanced cancers is a different approach with separate eligibility and safety requirements. Choosing a shorter schedule or particular machine requires more than comparing brand names. Before arranging care abroad, ask about urinary and bowel assessment, the possible need for hormone therapy, sexual and fertility effects, treatment visits and the long-term plan for PSA monitoring and symptom support.

Choosing treatment by risk and previous care

The team considers PSA, biopsy grade, disease extent, health and preferences. Localised cancer may be managed with surveillance, surgery or radiation according to risk. Higher-risk situations may require radiation with androgen deprivation therapy. After prostatectomy, a rising PSA can prompt discussion of salvage radiation; this is different from routinely treating everyone immediately after surgery. Advanced disease needs its own assessment of systemic therapy and any useful local treatment.

External beam radiation and brachytherapy

External beam treatment uses a machine to deliver radiation to the prostate or a defined postoperative area, sometimes including pelvic nodes. Image guidance helps account for movement and positioning. Brachytherapy places sources close to the target using temporary treatment or permanent seeds in selected patients. Urinary symptoms, gland size, anatomy and previous procedures can affect suitability. Neither a proton beam nor a named stereotactic system guarantees better results for every patient.

Planning the course

A planning scan maps the target and surrounding bladder and rectum. Follow the centre's bladder filling and bowel preparation instructions. Some plans use implanted markers or a rectal spacer; these involve procedures with their own risks and are not universally required. Shorter external radiation schedules are established options, while the exact prescription depends on the treatment setting. Clarify the duration of any hormone therapy and how its effects will be monitored. Do not adjust medicines independently.

Side effects and PSA follow-up

Urinary frequency, burning, bowel irritation and fatigue can occur. Later problems may include erectile dysfunction, bleeding or persistent urinary and bowel changes. Discuss fertility preservation before treatment if relevant. Inability to urinate, significant bleeding or severe pain needs prompt medical advice. After primary radiation, PSA often falls gradually and a temporary rise can occur; interpretation uses the pattern over time and the treatment context. Obtain a follow-up schedule and support contacts at home. Related information includes brachytherapy and radiotherapy.

Frequently asked questions

Will hormone therapy always be needed?

No. Its role and duration depend on risk, disease extent and the planned radiation approach.

Will external radiation make me radioactive?

No. Seeds or radiopharmaceuticals require their own instructions, so clarify which treatment is proposed.

Does PSA have to become zero?

After radiation with the prostate remaining, PSA is interpreted differently from PSA after prostatectomy. Ask the team to explain your results.

Can a short course be chosen for travel convenience?

Only if it is clinically suitable. Treatment safety and disease control guide the prescription.